Kawasaki disease

Pediatr Clin North Am. 1995 Oct;42(5):1205-22. doi: 10.1016/s0031-3955(16)40059-3.

Abstract

This article is an up-to-date review of issues surrounding Kawasaki disease, with particular emphasis on the immunologic aspects. Kawasaki disease is now the leading cause of acquired heart disease in children in most developed countries.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Aspirin / therapeutic use
  • Child
  • Child, Preschool
  • Coronary Disease / etiology
  • Diagnosis, Differential
  • Female
  • Humans
  • Male
  • Mucocutaneous Lymph Node Syndrome* / complications
  • Mucocutaneous Lymph Node Syndrome* / diagnosis
  • Mucocutaneous Lymph Node Syndrome* / drug therapy
  • Mucocutaneous Lymph Node Syndrome* / immunology
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prognosis

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Platelet Aggregation Inhibitors
  • Aspirin